Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Jendle

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
The Lancet. Diabetes & Endocrinology|September 18, 2020
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trialsPer-Henrik Groop, Paresh Dandona, Moshe Phillip, et al.
Evidence-Based Mental Health|November 17, 2022
Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorderMaja Dobrosavljevic, Seena Fazel, Ebba Du Rietz, et al.
Frontiers in Endocrinology|October 16, 2024
Clinical perspective on innovative insulin delivery technologies in diabetes managementGüvenç Koçkaya, Tadej Battelino, Goran Petrovski, et al.
Diabetes, Obesity & Metabolism|October 8, 2025
A systematic literature review and meta-analysis of real-world evidence on commercially available automated insulin delivery systems in people with type 1 diabetesJohannes Pöhlmann, Jayne Smith-Palmer, Erik H Serné, et al.
Neuroscience and Biobehavioral Reviews|February 8, 2023
The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling studyMiguel Garcia-Argibay, Lin Li, Ebba Du Rietz, et al.
Journal of Diabetes Science and Technology|May 6, 2025
Recommendations on the Collection of Comparator Measurement Data in the Performance Evaluation of Continuous Glucose Monitoring SystemsGuido Freckmann, Stefan Pleus, Manuel Eichenlaub, et al.
EJIFCC|October 16, 2025
Recommendations on the Collection of Comparator Measurement Data in the Performance Evaluation of Continuous Glucose Monitoring SystemsGuido Freckmann, Stefan Pleus, Manuel Eichenlaub, et al.
Journal of Diabetes Science and Technology|November 14, 2024
The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose MonitoringStefan Pleus, Manuel Eichenlaub, Elisabet Eriksson Boija, et al.
Journal of Diabetes Science and Technology|August 21, 2023
Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for ReportingGuido Freckmann, Manuel Eichenlaub, Delia Waldenmaier, et al.
Diabetes, Obesity & Metabolism|April 28, 2025
Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGMStefan Pleus, Manuel Eichenlaub, Elisabet Eriksson Boija, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
The Lancet. Diabetes & Endocrinology|September 18, 2020
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trialsPer-Henrik Groop, Paresh Dandona, Moshe Phillip, et al.
Evidence-Based Mental Health|November 17, 2022
Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorderMaja Dobrosavljevic, Seena Fazel, Ebba Du Rietz, et al.
Frontiers in Endocrinology|October 16, 2024
Clinical perspective on innovative insulin delivery technologies in diabetes managementGüvenç Koçkaya, Tadej Battelino, Goran Petrovski, et al.
Diabetes, Obesity & Metabolism|October 8, 2025
A systematic literature review and meta-analysis of real-world evidence on commercially available automated insulin delivery systems in people with type 1 diabetesJohannes Pöhlmann, Jayne Smith-Palmer, Erik H Serné, et al.
Neuroscience and Biobehavioral Reviews|February 8, 2023
The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling studyMiguel Garcia-Argibay, Lin Li, Ebba Du Rietz, et al.
Journal of Diabetes Science and Technology|May 6, 2025
Recommendations on the Collection of Comparator Measurement Data in the Performance Evaluation of Continuous Glucose Monitoring SystemsGuido Freckmann, Stefan Pleus, Manuel Eichenlaub, et al.
EJIFCC|October 16, 2025
Recommendations on the Collection of Comparator Measurement Data in the Performance Evaluation of Continuous Glucose Monitoring SystemsGuido Freckmann, Stefan Pleus, Manuel Eichenlaub, et al.
Journal of Diabetes Science and Technology|November 14, 2024
The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose MonitoringStefan Pleus, Manuel Eichenlaub, Elisabet Eriksson Boija, et al.
Journal of Diabetes Science and Technology|August 21, 2023
Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for ReportingGuido Freckmann, Manuel Eichenlaub, Delia Waldenmaier, et al.
Diabetes, Obesity & Metabolism|April 28, 2025
Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGMStefan Pleus, Manuel Eichenlaub, Elisabet Eriksson Boija, et al.
Pageof 10